Advertisement

Value Based Payment Shift for Independent Urology Practices: Roadmap and Barriers

Published:October 21, 2022DOI:https://doi.org/10.1016/j.urology.2022.10.008
      Value-based payment (VBP) reform remains an increasingly relevant path for health care transformation. VBP aligns financial incentives with higher quality care at a lower cost for patient populations. This bipartisan commitment to VBP remains a top priority for the Centers for Medicare and Medicaid Services (CMS) with a goal to include all Medicare beneficiaries in a VBP model with accountability for total cost of care and quality by 2030.
      • Brooks-LaSure C
      • Fowler E
      • Seshamani M
      • Tsai D.
      Innovation at the centers for medicare and medicaid services: avision for the next 10 years | health affairs.
      Further, the COVID-19 public health emergency highlighted the dependency of the fee-for-service (FFS) payment system on patient volume. Practices reliant on FFS faced severe financial challenges when in-person visits were not feasible.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Brooks-LaSure C
        • Fowler E
        • Seshamani M
        • Tsai D.
        Innovation at the centers for medicare and medicaid services: avision for the next 10 years | health affairs.
        Health Affairs Blog. 2021; (Published Accessed November 2, 2021)
      1. Makarov D v, Penson, David F. The state of the urology workforce and practice in the United States; 2021. https://www.AUAnet.org/common/pdf/.

        • Kaye DR
        • Miller DC
        • Ellimoottil C.
        Alternative payment models and urology.
        Curr Opin Urol. 2017; 27: 360-365https://doi.org/10.1097/mou.0000000000000403
      2. MIPS Value Pathways (MVPs): which path is right for you? 2017 https://blog.medisolv.com/articles/mips-value-pathways. Accessed May 4, 2022.

        • Federal Register
        Medicare Program; CY 2022 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment Policies; Medicare Shared Savings Program Requirements; Provider Enrollment Regulation Updates; and Provider and Supplier Prepayment and Post-Payment Medical Review Requirements.
        2021 (Accessed April 28, 2022)
        • Healthcare Payment Learning and Action Network
        Alternative Payment Model (APM) Framework.
        2017
        • Shore ND
        • Kapoor DA
        • Goldfischer ER
        • et al.
        Preserving independent urology: LUGPA's first decade.
        Rev Urol. 2019; 21: 102-108
        • Gaylis FD
        • Cooperberg MR
        • Loeb S
        • et al.
        Conservative management of low-risk prostate cancer: apath to value-based care.
        Urol Pract. 2022; 9: 195-197https://doi.org/10.1097/UPJ.0000000000000297
      3. Enhancing Oncology Model.
        CMS Innovation Center, 2022 (Accessed September 23, 2022)
      4. Kaplan AL, Ellimoottil C, Rosenthal JT. Five lessons from 30 years of bundled payments. Health Affairs Forefront. https://doi.org/10.1377/FOREFRONT.20161003.056892

      5. Radiation Oncology Model. CMS Innovation Center. 2022. https://innovation.cms.gov/innovation-models/radiation-oncology-model. Accessed September 23, 2022.

      6. Differential Impact on OCM Performance by Cancer Type During COVID-19 PHE Avalere Health. 2022. https://avalere.com/insights/differential-impact-on-ocm-performance-by-cancer-type-during-covid-19-public-health-emergency-phe. Accessed September 24, 2022.

        • Kapoor DA
        • Shore ND
        • Kirsh GM
        • Henderson J
        • Cohen TD
        • Latino K.
        The LUGPA alternative payment model for initial therapy of newly diagnosed patients with organ-confined prostate cancer: rationale and development.
        Rev Urol. 2017; 19: 235https://doi.org/10.3909/RIU0779
      7. Bundled Pay Prometheus Analytics. 2022 http://www.prometheusanalytics.net/products/prometheus-bundlepay. Accessed April 28, 2022.

        • Peterson C
        • Grosse SD
        • Dunn A.
        A practical guide to episode groupers for cost-of-illness analysis in health services research.
        SAGE Open Med. 2019; 7205031211984020https://doi.org/10.1177/2050312119840200
      8. BPCI Advanced.
        CMS Innovation Center, 2022 (Accessed July 16, 2022)
      9. Pathways for Specialty Care Coordination and Integration in Population-based Models.
        CMS, 2022 (Accessed July 16, 2022)
        • Hollenbeck BK
        • Kaufman SR
        • Borza T
        • et al.
        Accountable care organizations and prostate cancer care.
        Urol Pract. 2017; 4: 454-461https://doi.org/10.1016/j.urpr.2016.11.001
        • Trinh QD
        • Sun M
        • Krasnova A
        • et al.
        Impact of accountable care organizations on prostate cancer screening and biopsies in the United States.
        Urol Pract. 2019; 6: 159-164https://doi.org/10.1016/J.URPR.2018.07.003
        • Resnick MJ
        • Graves AJ
        • Thapa S
        • et al.
        Medicare accountable care organization enrollment and appropriateness of cancer screening.
        JAMA Intern Med. 2018; 178: 648-654https://doi.org/10.1001/JAMAINTERNMED.2017.8087
        • Modi PK
        • Kaufman SR
        • Borza T
        • et al.
        Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
        Cancer. 2018; 124: 3364-3371https://doi.org/10.1002/CNCR.31573
        • Reid RO
        • Tom AK
        • Ross RM
        • Duffy EL
        • Damberg CL.
        Physician compensation arrangements and financial performance incentives in US health systems.
        JAMA Health Forum. 2022; 3e214634https://doi.org/10.1001/JAMAHEALTHFORUM.2021.4634
        • Gadzinski AJ
        • Andino JJ
        • Odisho AY
        • Watts KL
        • Gore JL
        • Ellimoottil C.
        Telemedicine and eConsults for hospitalized patients during COVID-19.
        Urology. 2020; 141: 12https://doi.org/10.1016/J.UROLOGY.2020.04.061
        • Song Z
        • Kannan S
        • Gambrel RJ
        • et al.
        Physician practice pattern variations in common clinical scenarios within 5 US metropolitan areas.
        JAMA Health Forum. 2022; 3: e214698https://doi.org/10.1001/JAMAHEALTHFORUM.2021.4698